CAH · News · 20260804N

Competition and Market Share

CARDINAL HEALTH INC · 2026-08-04 · Importance 17 · Surprise 24

Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly performing strongly and helping offset industry headwinds. McKesson is also benefiting from specialty pharmaceuticals, oncology services, and prescription-volume growth, reinforcing specialty distribution as a key competitive battleground.

Key facts

• For the quarter ended June 2026, the consensus EPS estimate is $2.42 per share and Cardinal Health has a Zacks Rank #2 and an Earnings ESP of +1.24%. source